Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Ane Ulazia-Garmendia"'
1
Akademický článek
A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis
Autor: Saioa Mendaza, David Guerrero-Setas, Iñaki Monreal-Santesteban, Ane Ulazia-Garmendia, Alicia Cordoba Iturriagagoitia, Susana De la Cruz, Esperanza Martín-Sánchez
Publikováno v: Biomedicines, Vol 9, Iss 10, p 1394 (2021)
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer (BC) subtype and lacks targeted treatment. It is diagnosed by the absence of immunohistochemical expression of several biomarkers, but this method still displays some interlabo
Externí odkaz: https://doaj.org/article/0b8dc928960b41349bf05e3df61ac812
Zobrazit plný text záznamu
2
Akademický článek
ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer
Autor: Saioa Mendaza, Ane Ulazia-Garmendia, Iñaki Monreal-Santesteban, Alicia Córdoba, Yerani Ruiz de Azúa, Begoña Aguiar, Raquel Beloqui, Pedro Armendáriz, Marta Arriola, Esperanza Martín-Sánchez, David Guerrero-Setas
Publikováno v: International Journal of Molecular Sciences, Vol 21, Iss 3, p 903 (2020)
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and currently lacks any effective targeted therapy. Since epigenetic alterations are a common event in TNBC, DNA methylation profiling can be useful for identifying pot
Externí odkaz: https://doaj.org/article/e3ee65772e694c019134299a047040ae
Zobrazit plný text záznamu
3
A DNA methylation-based gene signature can predict triple-negative breast cancer diagnosis
Autor: Alicia Cordoba Iturriagagoitia, Esperanza Martín-Sánchez, Iñaki Monreal-Santesteban, Ane Ulazia-Garmendia, David Guerrero-Setas, Susana De La Cruz, Saioa Mendaza
Publikováno v: Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Biomedicines
Volume 9
Issue 10
Biomedicines, Vol 9, Iss 1394, p 1394 (2021)
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer (BC) subtype and lacks targeted treatment. It is diagnosed by the absence of immunohistochemical expression of several biomarkers, but this method still displays some interlabo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b58b9b18efb5c78590383cd6a5156830
https://hdl.handle.net/2454/42653
Zobrazit plný text záznamu
4
ADAM12 is a potential therapeutic target regulated by hypomethylation in triple-negative breast cancer
Autor: Begoña Aguiar, Raquel Beloqui, Yerani Ruiz de Azúa, Iñaki Monreal-Santesteban, Marta Arriola, Alicia Córdoba, David Guerrero-Setas, Ane Ulazia-Garmendia, Pedro Armendáriz, Esperanza Martín-Sánchez, Saioa Mendaza
Publikováno v: Academica-e: Repositorio Institucional de la Universidad Pública de Navarra
Universidad Pública de Navarra
International Journal of Molecular Sciences, Vol 21, Iss 3, p 903 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 3
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and currently lacks any effective targeted therapy. Since epigenetic alterations are a common event in TNBC, DNA methylation profiling can be useful for identifying pot
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668f749a61183d0a57ca32d99c25d130
https://hdl.handle.net/2454/37754
Zobrazit plný text záznamu
5
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
Autor: Francisco Vicente-Garcia, Ane Ulazia-Garmendia, Esperanza Martín-Sánchez, David Guerrero-Setas, Alicia Córdoba, Iñaki Monreal-Santesteban, Idoia Blanco-Luquin, Susana De La Cruz, Ana Aramendia, Saioa Mendaza
Publikováno v: Academica-e: Repositorio Institucional de la Universidad Pública de Navarra
Universidad Pública de Navarra
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Clinical Epigenetics
Background: Cadherin-like protein 22 (CDH22) is a transmembrane glycoprotein involved in cell-cell adhesion and metastasis. Its role in cancer is controversial because it has been described as being upregulated in colorectal cancer, whereas it is dow
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5bc5a9f46f7dd769b394d44c36af9b9
https://doi.org/10.1186/s13148-016-0309-z
Zobrazit plný text záznamu
6
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
Autor: David Guerrero-Setas, Noemi Perez-Janices, Iñaki Monreal-Santesteban, Francisco Vicente-Garcia, Idoia Blanco-Luquin, Manel Esteller, Diego Megías, Esperanza Martín-Sánchez, Ane Ulazia-Garmendia, Paula Lopez-Serra, David Escors, Jose Juan Illarramendi, Alicia Córdoba, Saioa Mendaza
Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Repisalud
Instituto de Salud Carlos III (ISCIII)
Academica-e: Repositorio Institucional de la Universidad Pública de Navarra
Universidad Pública de Navarra
Oncotarget
The CHL1 gene encodes a cell-adhesion molecule proposed as being a putative tumour-suppressor gene in breast cancer (BC). However, neither the underlying molecular mechanisms nor the clinical value of CHL1 downregulation in BC has been explored. The
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9085ebe7251266669318ba13c1a23b0b
https://hdl.handle.net/2454/32047
Zobrazit plný text záznamu
7
PO-388 Epigenetic silencing of ZNF177 by MIR-877–3 p could be involved in cervical cancer progression
Autor: Saioa Mendaza, Esperanza Martín-Sánchez, Rosa Guarch, X.M. Guiu, J. Santos Salas, David Guerrero-Setas, Ane Ulazia-Garmendia, Iñaki Monreal-Santesteban, August Vidal, Idoia Blanco-Luquin
Publikováno v: ESMO Open. 3:A174
Introduction Cervical cancer (CC) is the fourth most common cancer among women worldwide, with around 50% of mortality. Therefore, new prognostic biomarkers are necessary to improve its poor outcome. Micro-RNAs (miRs) are small non-coding RNAs, mainl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2daebea5cd6fcaa57914ec7357256e29
https://doi.org/10.1136/esmoopen-2018-eacr25.415
Zobrazit plný text záznamu
8
Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA
Autor: E. Pernaut-Leza, Francisco Vicente-Garcia, Noemi Perez-Janices, David Guerrero-Setas, J. Pérez Vizcaino, Idoia Blanco-Luquin, Ane Ulazia-Garmendia, Saioa Mendaza, Esperanza Martín-Sánchez, Iñaki Monreal-Santesteban, David Escors, Alicia Córdoba, M. J. Díaz De Cerio
Publikováno v: Virchows Archiv : an international journal of pathology. 469(1)
We analysed the promoter methylation status of five genes, involved in adhesion (EPB41L3, TSLC-1), apoptosis (RASSF1, RASSF2) or angiogenesis (TSP-1), in intraoperative sentinel lymph node (SLN) biopsy samples from patients with breast cancer, that h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28baef6db31a2fac6d4bbfdbf01d4c50
https://pubmed.ncbi.nlm.nih.gov/27097811
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje